Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
Telomir Pharmaceuticals | 5: Annual statement of changes in beneficial ownership of securities-Officer Aminov Erez
Telomir Pharmaceuticals | 10-K: FY2024 Annual Report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Bay Shore Trust
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Yanez Michelle
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jerman Michael Allen
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MacPherson Edward Clouston
Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Yanez Michelle